When.com Web Search

  1. Ads

    related to: premenopausal breast cancer treatment guidelines figo

Search results

  1. Results From The WOW.Com Content Network
  2. International Federation of Gynaecology and Obstetrics

    en.wikipedia.org/wiki/International_Federation...

    In addition the society sponsors fellowships, lectures, provides reports about women's health, and offers grants. Importantly through international committees consensus guidelines are achieved about evaluation and treatment of gynecological and obstetrical disorders. German stamp, XI FIGO World Congress 1985

  3. Breast cancer management - Wikipedia

    en.wikipedia.org/wiki/Breast_cancer_management

    Staging breast cancer is the initial step to help physicians determine the most appropriate course of treatment. As of 2016, guidelines incorporated biologic factors, such as tumor grade, cellular proliferation rate, estrogen and progesterone receptor expression, human epidermal growth factor 2 (HER2) expression, and gene expression profiling into the staging system.

  4. Hormone replacement therapy - Wikipedia

    en.wikipedia.org/wiki/Hormone_replacement_therapy

    In older patients, there was an apparent increased incidence of breast cancer, heart attacks, venous thrombosis, and stroke, although a reduced incidence of colorectal cancer and bone fracture. At the time, The WHI recommended that women with non-surgical menopause take the lowest feasible dose of HRT for the shortest possible time to minimize ...

  5. Progestogen-only pill - Wikipedia

    en.wikipedia.org/wiki/Progestogen-only_pill

    They concluded that: "Overall, there was no evidence of an increased risk of breast cancer". [53] Recent anxieties about the contribution of progestogens to the increased risk of breast cancer associated with HRT in postmenopausal women such as found in the WHI trials [54] have not spread to progestogen-only contraceptive use in premenopausal ...

  6. Aromatase inhibitor - Wikipedia

    en.wikipedia.org/wiki/Aromatase_inhibitor

    Aromatase inhibitors (AIs) are a class of drugs used in the treatment of breast cancer in postmenopausal women and in men, [1] [2] and gynecomastia in men. They may also be used off-label to reduce estrogen conversion when supplementing testosterone exogenously. They may also be used for chemoprevention in women at high risk for breast cancer.

  7. Collaborative Group on Hormonal Factors in Breast Cancer

    en.wikipedia.org/wiki/Collaborative_Group_on...

    One of their recent publications was a 2019 meta-analysis of menopausal hormone therapy and breast cancer risk based on type and timing of therapy. [1] In 2012, the group concluded in a meta-analysis of 117 studies that the incidence of breast cancer was increased by each year younger at menarche and each year older at menopause. [4]

  1. Ads

    related to: premenopausal breast cancer treatment guidelines figo